Research Articles | Page 9 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
PNH Phenotypes and Their Genesis Jun 2020 British Journal of Haematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis Jun 2020 Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation Myelodysplastic Syndromes (MDS)
MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? Jun 2020 Best practice & research. Clinical haematology Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
In Search for a Haemoglobin Threshold in Myelodysplastic Syndromes Jun 2020 British Journal of Haematology Myelodysplastic Syndromes (MDS)
Immunomodulation With Pomalidomide at Early Lymphocyte Recovery After Induction Chemotherapy in Newly Diagnosed AML and High-Risk MDS Jun 2020 Leukemia Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia Jun 2020 Haematologica Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro Jun 2020 Experimental Hematology Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Myelodysplastic Syndromes: A Review of Therapeutic Progress Over the Past 10 Years Jun 2020 Expert Review of Anticancer Therapy Myelodysplastic Syndromes (MDS)
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes Jun 2020 Clinical Lymphoma , Myeloma & Leukemia Myelodysplastic Syndromes (MDS)